What is a material adverse effect (MAE)?
What it means and how to read it on a deal.
What it is
An adverse change defined in the merger agreement. If a change meets the agreement's requirements, it can excuse the buyer from closing.
Some agreements count the extra harm an excluded event does to the target, beyond similar companies.
What the clause does
Say Woodgrove agrees to buy Litware for $50.00 a share. Before closing, Litware's sales fall sharply, and Woodgrove no longer wants to close.
Many merger agreements make it a closing condition that no material adverse effect has hit the target since signing.
If one has, the buyer may not have to close.
Whether the buyer can also end the agreement depends on the agreement. So does what each side must then do.
What usually doesn't count
The agreement defines the term. The definition matters more than the label.
It usually starts broad: any change materially adverse to the target's business, results or financial condition. Then it lists exceptions, often called carve-outs.
The carve-outs usually include:
- The economy and markets
- General economic, financial or market conditions.
- The industry
- Conditions across the target's industry.
- Law and accounting
- Changes in law or in accounting rules.
- Events
- War, terrorism and natural disasters.
- Pandemics
- Explicit pandemic exceptions increased quickly in early 2020. From February 1 to March 31, 2020, 13 of 17 public-target deals above $100 million had one.
- The deal itself
- Effects caused by announcing the deal, or by the deal being pending.
- Missed forecasts
- Missing projections. In many agreements, the reasons behind the miss can still count.
Some agreements let an excluded event count anyway if it hits the target harder than similar companies. Sometimes only the extra harm counts.
So if a recession hit Litware no harder than its rivals, its slump usually wouldn't count.
How courts have read it
Many agreements are governed by Delaware law.
In IBP v. Tyson Foods (2001), the Delaware Court of Chancery said a short-term dip in earnings isn't enough.
Courts ask whether the effect is expected to reduce the target's earnings power over years, not months. The decline doesn't have to have lasted years already.
In Hexion v. Huntsman (2008), the court rejected the buyer's claim. Its analysis included a projection of 2009 earnings about 3.6% below 2006's.
Akorn v. Fresenius, in October 2018, was the first Delaware decision to find a material adverse effect. It also upheld the buyer's termination.
The target's business had suffered a large, sustained decline after signing. The Delaware Supreme Court affirmed the decision in December 2018.
What it means for shareholders
A buyer can raise a material adverse effect as a reason not to close. The buyer has to prove it, and the target may dispute it in court, as in the cases above.
How a claim ends depends on that agreement's definition and on the facts.
If the buyer's claim is upheld, the deal can end without holders being paid the offer price.
Easily confused with
- Closing conditions
- The conditions that must be satisfied, or waived where allowed, before the deal closes. One is often that no material adverse effect has occurred.
- Financing condition
- Makes the buyer's obligation to close depend on getting the financing the agreement names. A material adverse effect is about the target's business.
Questions
What is a MAC clause?
A material adverse change clause, another name for the material adverse effect clause. If the target's business suffers a serious, lasting decline between signing and closing, the buyer may not have to close.
Can you give an example of a material adverse effect?
In Akorn v. Fresenius (2018), a Delaware court found one. The target's business had suffered a large, sustained decline after signing. The court upheld the buyer's termination.
Who has to prove a material adverse effect?
The buyer that claims it. Delaware courts look for an effect expected to last years, not months.
Sources
- Simpson Thacher, Delaware Supreme Court affirms Chancery decision finding a material adverse effect (2018)
- Akorn v. Fresenius Kabi, Delaware Court of Chancery (October 1, 2018), opinion
- Hexion Specialty Chemicals v. Huntsman, Delaware Court of Chancery (2008), opinion
- Cravath, COVID-19: impact on M&A and shareholder activism (April 2020)
Tracking AlphaBy Jera Value · Reviewed
Related terms
- Closing conditionsWhat must happen before the deal can close, such as holder approval, antitrust clearance or other approvals.
- Specific performanceThe target's right to ask a court to order the buyer to complete the deal, instead of only collecting a fee or damages.
- Reverse termination feeThe fee the buyer pays the target if the agreement ends in one of the cases it lists. Typically, a regulator refuses approval or the buyer's financing fails.